Amag wins FDA approval for kidney drug
Amag Pharmaceuticals has won Food and Drug Administration approval for its drug to treat chronic kidney disease, called Feraheme. The Lexington, Mass.-based company’s drug is applied via an injection and is designed to be used as an iron replacement therapy to... read the full story
Ex-schools chief apparently plagiarized Ph.D. work | 11/22/2009 04:00 PM
UNC 31, Boston College 13 | 11/21/2009 09:16 AM
Review: The Cherry Orchard at The Blue Theater | 11/20/2009 11:45 AM
Comments
Enter your personal information below, or sign in with your Facebook account by clicking the 'Connect with Facebook' button.
Lexington [...] chronic kidney disease, called Feraheme. The Lexington , Mass.-based company’s drug is applied via an [...]
Massachusetts [...] kidney disease, called Feraheme. The Lexington, Mass. -based company’s drug is applied via an injection [...]
Amag Pharmaceuticals [...] [...]
Despite blustery weather, Lafayette’s Walk-a-Thon rolls on | Add your comment
"Ancient Lands/Modern Landscapes: Aboriginal Paintings from Sandover River. | Add your comment
Urban Dare Phoenix tests brain, brawn | Add your comment
CDI Corp. extends work for IBM | Add your comment
Pullman woman sentenced to 20 months in jail for vehicular assault | Add your comment